Qualis Innovations, Inc.
Qualis Innovations, Inc. QLIS Peers
See (QLIS) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| QLIS | $0.27 | N/A | 5.5M | 2.22 | $0.12 | N/A |
| SMMNY | $27.74 | +1.40% | 124.2B | 25.87 | $1.07 | +1.07% |
| SEMHF | $55.00 | +0.18% | 61.7B | 25.70 | $2.14 | +1.80% |
| RYLPF | $24.37 | +2.79% | 23.1B | 81.22 | $0.30 | +3.90% |
| SONVY | $59.71 | -0.08% | 17.8B | 26.99 | $2.21 | +1.06% |
| SONVF | $301.20 | +0.00% | 17.8B | 27.02 | $11.03 | +1.76% |
| SNNUF | $15.58 | +7.23% | 13.6B | 33.15 | $0.47 | +2.41% |
| CHEOY | $98.64 | +2.00% | 12.9B | 53.75 | $1.84 | +1.41% |
| CHEOF | $185.50 | -2.78% | 12.1B | 50.54 | $3.67 | +1.49% |
| WILYY | $21.31 | +0.00% | 9.2B | 21.09 | $1.02 | N/A |
Stock Comparison
QLIS vs SMMNY Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, SMMNY has a market cap of 124.2B. Regarding current trading prices, QLIS is priced at $0.27, while SMMNY trades at $27.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas SMMNY's P/E ratio is 25.87. In terms of profitability, QLIS's ROE is -1.41%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, QLIS is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs SEMHF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, SEMHF has a market cap of 61.7B. Regarding current trading prices, QLIS is priced at $0.27, while SEMHF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas SEMHF's P/E ratio is 25.70. In terms of profitability, QLIS's ROE is -1.41%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, QLIS and SEMHF have similar daily volatility (0.00).
QLIS vs RYLPF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, RYLPF has a market cap of 23.1B. Regarding current trading prices, QLIS is priced at $0.27, while RYLPF trades at $24.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas RYLPF's P/E ratio is 81.22. In terms of profitability, QLIS's ROE is -1.41%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, QLIS and RYLPF have similar daily volatility (0.00).
QLIS vs SONVY Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, SONVY has a market cap of 17.8B. Regarding current trading prices, QLIS is priced at $0.27, while SONVY trades at $59.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas SONVY's P/E ratio is 26.99. In terms of profitability, QLIS's ROE is -1.41%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, QLIS is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs SONVF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, SONVF has a market cap of 17.8B. Regarding current trading prices, QLIS is priced at $0.27, while SONVF trades at $301.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas SONVF's P/E ratio is 27.02. In terms of profitability, QLIS's ROE is -1.41%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, QLIS and SONVF have similar daily volatility (0.00).
QLIS vs SNNUF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, SNNUF has a market cap of 13.6B. Regarding current trading prices, QLIS is priced at $0.27, while SNNUF trades at $15.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas SNNUF's P/E ratio is 33.15. In terms of profitability, QLIS's ROE is -1.41%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, QLIS and SNNUF have similar daily volatility (0.00).
QLIS vs CHEOY Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, CHEOY has a market cap of 12.9B. Regarding current trading prices, QLIS is priced at $0.27, while CHEOY trades at $98.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas CHEOY's P/E ratio is 53.75. In terms of profitability, QLIS's ROE is -1.41%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, QLIS is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs CHEOF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, CHEOF has a market cap of 12.1B. Regarding current trading prices, QLIS is priced at $0.27, while CHEOF trades at $185.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas CHEOF's P/E ratio is 50.54. In terms of profitability, QLIS's ROE is -1.41%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, QLIS and CHEOF have similar daily volatility (0.00).
QLIS vs WILYY Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, WILYY has a market cap of 9.2B. Regarding current trading prices, QLIS is priced at $0.27, while WILYY trades at $21.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas WILYY's P/E ratio is 21.09. In terms of profitability, QLIS's ROE is -1.41%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, QLIS and WILYY have similar daily volatility (0.00).
QLIS vs WILLF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, WILLF has a market cap of 8.6B. Regarding current trading prices, QLIS is priced at $0.27, while WILLF trades at $41.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas WILLF's P/E ratio is 20.37. In terms of profitability, QLIS's ROE is -1.41%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, QLIS and WILLF have similar daily volatility (0.00).
QLIS vs GNGBY Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, GNGBY has a market cap of 5.5B. Regarding current trading prices, QLIS is priced at $0.27, while GNGBY trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas GNGBY's P/E ratio is 35.61. In terms of profitability, QLIS's ROE is -1.41%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, QLIS is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs GNGBF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, GNGBF has a market cap of 4.8B. Regarding current trading prices, QLIS is priced at $0.27, while GNGBF trades at $18.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas GNGBF's P/E ratio is 33.02. In terms of profitability, QLIS's ROE is -1.41%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, QLIS and GNGBF have similar daily volatility (0.00).
QLIS vs AMBBY Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, AMBBY has a market cap of 4.1B. Regarding current trading prices, QLIS is priced at $0.27, while AMBBY trades at $15.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas AMBBY's P/E ratio is 74.57. In terms of profitability, QLIS's ROE is -1.41%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, QLIS and AMBBY have similar daily volatility (0.00).
QLIS vs AMBFF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, AMBFF has a market cap of 4.1B. Regarding current trading prices, QLIS is priced at $0.27, while AMBFF trades at $15.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas AMBFF's P/E ratio is 74.22. In terms of profitability, QLIS's ROE is -1.41%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, QLIS and AMBFF have similar daily volatility (0.00).
QLIS vs NHNKY Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, NHNKY has a market cap of 3.6B. Regarding current trading prices, QLIS is priced at $0.27, while NHNKY trades at $11.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas NHNKY's P/E ratio is 18.49. In terms of profitability, QLIS's ROE is -1.41%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, QLIS is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs NHNKF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, QLIS is priced at $0.27, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, QLIS's ROE is -1.41%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, QLIS and NHNKF have similar daily volatility (0.00).
QLIS vs GNNDY Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, GNNDY has a market cap of 2.2B. Regarding current trading prices, QLIS is priced at $0.27, while GNNDY trades at $46.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas GNNDY's P/E ratio is 18.12. In terms of profitability, QLIS's ROE is -1.41%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, QLIS is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs OSSFF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, OSSFF has a market cap of 2.2B. Regarding current trading prices, QLIS is priced at $0.27, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas OSSFF's P/E ratio is 30.00. In terms of profitability, QLIS's ROE is -1.41%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, QLIS and OSSFF have similar daily volatility (0.00).
QLIS vs STSEY Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, QLIS is priced at $0.27, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas STSEY's P/E ratio is 39.41. In terms of profitability, QLIS's ROE is -1.41%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, QLIS and STSEY have similar daily volatility (0.00).
QLIS vs VTRLY Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, VTRLY has a market cap of 2B. Regarding current trading prices, QLIS is priced at $0.27, while VTRLY trades at $14.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas VTRLY's P/E ratio is 38.21. In terms of profitability, QLIS's ROE is -1.41%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, QLIS and VTRLY have similar daily volatility (0.00).
QLIS vs MCRPF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, MCRPF has a market cap of 1.9B. Regarding current trading prices, QLIS is priced at $0.27, while MCRPF trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas MCRPF's P/E ratio is -8.67. In terms of profitability, QLIS's ROE is -1.41%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, QLIS and MCRPF have similar daily volatility (0.00).
QLIS vs GGNDF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, GGNDF has a market cap of 1.8B. Regarding current trading prices, QLIS is priced at $0.27, while GGNDF trades at $14.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas GGNDF's P/E ratio is 14.26. In terms of profitability, QLIS's ROE is -1.41%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, QLIS and GGNDF have similar daily volatility (0.00).
QLIS vs DWRKF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, QLIS is priced at $0.27, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, QLIS's ROE is -1.41%, compared to DWRKF's ROE of N/A. Regarding short-term risk, QLIS and DWRKF have similar daily volatility (0.00).
QLIS vs OSSUY Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, QLIS is priced at $0.27, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, QLIS's ROE is -1.41%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, QLIS and OSSUY have similar daily volatility (0.00).
QLIS vs MEDGF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, QLIS is priced at $0.27, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, QLIS's ROE is -1.41%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, QLIS and MEDGF have similar daily volatility (0.00).
QLIS vs DRWKF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, DRWKF has a market cap of 1.4B. Regarding current trading prices, QLIS is priced at $0.27, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas DRWKF's P/E ratio is 9.97. In terms of profitability, QLIS's ROE is -1.41%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, QLIS and DRWKF have similar daily volatility (0.00).
QLIS vs DGWPF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, DGWPF has a market cap of 1.2B. Regarding current trading prices, QLIS is priced at $0.27, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas DGWPF's P/E ratio is 7.81. In terms of profitability, QLIS's ROE is -1.41%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, QLIS and DGWPF have similar daily volatility (0.00).
QLIS vs ELEAF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, ELEAF has a market cap of 1B. Regarding current trading prices, QLIS is priced at $0.27, while ELEAF trades at $12.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas ELEAF's P/E ratio is 14.27. In terms of profitability, QLIS's ROE is -1.41%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, QLIS and ELEAF have similar daily volatility (0.00).
QLIS vs XVIPF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, XVIPF has a market cap of 948.1M. Regarding current trading prices, QLIS is priced at $0.27, while XVIPF trades at $30.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas XVIPF's P/E ratio is 65.43. In terms of profitability, QLIS's ROE is -1.41%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, QLIS and XVIPF have similar daily volatility (0.00).
QLIS vs LFTSF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, LFTSF has a market cap of 858.1M. Regarding current trading prices, QLIS is priced at $0.27, while LFTSF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas LFTSF's P/E ratio is 19.50. In terms of profitability, QLIS's ROE is -1.41%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, QLIS is less volatile compared to LFTSF. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs MDRSF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, MDRSF has a market cap of 639.5M. Regarding current trading prices, QLIS is priced at $0.27, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas MDRSF's P/E ratio is 151.47. In terms of profitability, QLIS's ROE is -1.41%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, QLIS and MDRSF have similar daily volatility (0.00).
QLIS vs CALZF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, CALZF has a market cap of 559.2M. Regarding current trading prices, QLIS is priced at $0.27, while CALZF trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas CALZF's P/E ratio is 80.95. In terms of profitability, QLIS's ROE is -1.41%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, QLIS and CALZF have similar daily volatility (0.00).
QLIS vs CLVSF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, CLVSF has a market cap of 556.5M. Regarding current trading prices, QLIS is priced at $0.27, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas CLVSF's P/E ratio is 38.25. In terms of profitability, QLIS's ROE is -1.41%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, QLIS and CLVSF have similar daily volatility (0.00).
QLIS vs AVMR Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, QLIS is priced at $0.27, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas AVMR's P/E ratio is -18.34. In terms of profitability, QLIS's ROE is -1.41%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, QLIS and AVMR have similar daily volatility (0.00).
QLIS vs IOBCF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, IOBCF has a market cap of 390.9M. Regarding current trading prices, QLIS is priced at $0.27, while IOBCF trades at $13.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas IOBCF's P/E ratio is 37.07. In terms of profitability, QLIS's ROE is -1.41%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, QLIS and IOBCF have similar daily volatility (0.00).
QLIS vs HYBT Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, QLIS is priced at $0.27, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas HYBT's P/E ratio is N/A. In terms of profitability, QLIS's ROE is -1.41%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, QLIS and HYBT have similar daily volatility (0.00).
QLIS vs EAPIF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, EAPIF has a market cap of 349.5M. Regarding current trading prices, QLIS is priced at $0.27, while EAPIF trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas EAPIF's P/E ratio is -2.28. In terms of profitability, QLIS's ROE is -1.41%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, QLIS and EAPIF have similar daily volatility (0.00).
QLIS vs CSSPF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, CSSPF has a market cap of 271.3M. Regarding current trading prices, QLIS is priced at $0.27, while CSSPF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, QLIS's ROE is -1.41%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, QLIS and CSSPF have similar daily volatility (0.00).
QLIS vs CLLKF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, CLLKF has a market cap of 258.3M. Regarding current trading prices, QLIS is priced at $0.27, while CLLKF trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas CLLKF's P/E ratio is -8.31. In terms of profitability, QLIS's ROE is -1.41%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, QLIS and CLLKF have similar daily volatility (0.00).
QLIS vs CYBQY Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, CYBQY has a market cap of 257.9M. Regarding current trading prices, QLIS is priced at $0.27, while CYBQY trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas CYBQY's P/E ratio is -50.50. In terms of profitability, QLIS's ROE is -1.41%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, QLIS and CYBQY have similar daily volatility (0.00).
QLIS vs HTLZF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, QLIS is priced at $0.27, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, QLIS's ROE is -1.41%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, QLIS and HTLZF have similar daily volatility (0.00).
QLIS vs BCCOY Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, BCCOY has a market cap of 221M. Regarding current trading prices, QLIS is priced at $0.27, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, QLIS's ROE is -1.41%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, QLIS and BCCOY have similar daily volatility (0.00).
QLIS vs IMPZY Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, IMPZY has a market cap of 199.9M. Regarding current trading prices, QLIS is priced at $0.27, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, QLIS's ROE is -1.41%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, QLIS and IMPZY have similar daily volatility (0.00).
QLIS vs DMTRF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, DMTRF has a market cap of 193.2M. Regarding current trading prices, QLIS is priced at $0.27, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, QLIS's ROE is -1.41%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, QLIS and DMTRF have similar daily volatility (0.00).
QLIS vs DTXMF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, QLIS is priced at $0.27, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, QLIS's ROE is -1.41%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, QLIS and DTXMF have similar daily volatility (0.00).
QLIS vs BRNHF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, BRNHF has a market cap of 161.9M. Regarding current trading prices, QLIS is priced at $0.27, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, QLIS's ROE is -1.41%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, QLIS and BRNHF have similar daily volatility (0.00).
QLIS vs CYBQF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, CYBQF has a market cap of 161.5M. Regarding current trading prices, QLIS is priced at $0.27, while CYBQF trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas CYBQF's P/E ratio is -60.50. In terms of profitability, QLIS's ROE is -1.41%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, QLIS and CYBQF have similar daily volatility (0.00).
QLIS vs PXMBF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, PXMBF has a market cap of 154.5M. Regarding current trading prices, QLIS is priced at $0.27, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, QLIS's ROE is -1.41%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, QLIS and PXMBF have similar daily volatility (0.00).
QLIS vs EKDHF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, EKDHF has a market cap of 152.7M. Regarding current trading prices, QLIS is priced at $0.27, while EKDHF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas EKDHF's P/E ratio is 17.00. In terms of profitability, QLIS's ROE is -1.41%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, QLIS and EKDHF have similar daily volatility (0.00).
QLIS vs BRSYF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, BRSYF has a market cap of 128.5M. Regarding current trading prices, QLIS is priced at $0.27, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, QLIS's ROE is -1.41%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, QLIS and BRSYF have similar daily volatility (0.00).
QLIS vs VMTHF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, VMTHF has a market cap of 125.7M. Regarding current trading prices, QLIS is priced at $0.27, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas VMTHF's P/E ratio is -1.25. In terms of profitability, QLIS's ROE is -1.41%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, QLIS and VMTHF have similar daily volatility (0.00).
QLIS vs AMEUF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, QLIS is priced at $0.27, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, QLIS's ROE is -1.41%, compared to AMEUF's ROE of -5.13%. Regarding short-term risk, QLIS is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs AVHHL Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, AVHHL has a market cap of 115.6M. Regarding current trading prices, QLIS is priced at $0.27, while AVHHL trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas AVHHL's P/E ratio is -1.83. In terms of profitability, QLIS's ROE is -1.41%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, QLIS and AVHHL have similar daily volatility (0.00).
QLIS vs FDMDF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, FDMDF has a market cap of 106.1M. Regarding current trading prices, QLIS is priced at $0.27, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, QLIS's ROE is -1.41%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, QLIS and FDMDF have similar daily volatility (0.00).
QLIS vs JMDMF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, JMDMF has a market cap of 104.4M. Regarding current trading prices, QLIS is priced at $0.27, while JMDMF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas JMDMF's P/E ratio is -27.83. In terms of profitability, QLIS's ROE is -1.41%, compared to JMDMF's ROE of N/A. Regarding short-term risk, QLIS and JMDMF have similar daily volatility (0.00).
QLIS vs SOMNF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, SOMNF has a market cap of 92.1M. Regarding current trading prices, QLIS is priced at $0.27, while SOMNF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas SOMNF's P/E ratio is -14.20. In terms of profitability, QLIS's ROE is -1.41%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, QLIS and SOMNF have similar daily volatility (0.00).
QLIS vs RSHUF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, QLIS is priced at $0.27, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, QLIS's ROE is -1.41%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, QLIS is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs SNZZF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, SNZZF has a market cap of 86.1M. Regarding current trading prices, QLIS is priced at $0.27, while SNZZF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas SNZZF's P/E ratio is -5.50. In terms of profitability, QLIS's ROE is -1.41%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, QLIS and SNZZF have similar daily volatility (0.00).
QLIS vs CKMTF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, QLIS is priced at $0.27, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, QLIS's ROE is -1.41%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, QLIS and CKMTF have similar daily volatility (0.00).
QLIS vs IPDQF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, IPDQF has a market cap of 66.9M. Regarding current trading prices, QLIS is priced at $0.27, while IPDQF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas IPDQF's P/E ratio is -3.30. In terms of profitability, QLIS's ROE is -1.41%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, QLIS is less volatile compared to IPDQF. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs BLOZF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, BLOZF has a market cap of 52.5M. Regarding current trading prices, QLIS is priced at $0.27, while BLOZF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas BLOZF's P/E ratio is -22.81. In terms of profitability, QLIS's ROE is -1.41%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, QLIS is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs RDGL Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, RDGL has a market cap of 50.7M. Regarding current trading prices, QLIS is priced at $0.27, while RDGL trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas RDGL's P/E ratio is -11.19. In terms of profitability, QLIS's ROE is -1.41%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, QLIS is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs NVYTF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, NVYTF has a market cap of 38.1M. Regarding current trading prices, QLIS is priced at $0.27, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas NVYTF's P/E ratio is -0.73. In terms of profitability, QLIS's ROE is -1.41%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, QLIS and NVYTF have similar daily volatility (0.00).
QLIS vs TLTFF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, TLTFF has a market cap of 35.8M. Regarding current trading prices, QLIS is priced at $0.27, while TLTFF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas TLTFF's P/E ratio is -14.26. In terms of profitability, QLIS's ROE is -1.41%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, QLIS is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs ELXMF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, ELXMF has a market cap of 28.4M. Regarding current trading prices, QLIS is priced at $0.27, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, QLIS's ROE is -1.41%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, QLIS and ELXMF have similar daily volatility (0.00).
QLIS vs MKEAF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, QLIS is priced at $0.27, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, QLIS's ROE is -1.41%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, QLIS and MKEAF have similar daily volatility (0.00).
QLIS vs PLLWF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, PLLWF has a market cap of 24.1M. Regarding current trading prices, QLIS is priced at $0.27, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas PLLWF's P/E ratio is -2.00. In terms of profitability, QLIS's ROE is -1.41%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, QLIS and PLLWF have similar daily volatility (0.00).
QLIS vs KBBTF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, QLIS is priced at $0.27, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, QLIS's ROE is -1.41%, compared to KBBTF's ROE of N/A. Regarding short-term risk, QLIS and KBBTF have similar daily volatility (0.00).
QLIS vs EMITF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, EMITF has a market cap of 22.3M. Regarding current trading prices, QLIS is priced at $0.27, while EMITF trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas EMITF's P/E ratio is -14.36. In terms of profitability, QLIS's ROE is -1.41%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, QLIS and EMITF have similar daily volatility (0.00).
QLIS vs POSC Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, POSC has a market cap of 21M. Regarding current trading prices, QLIS is priced at $0.27, while POSC trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas POSC's P/E ratio is 0.34. In terms of profitability, QLIS's ROE is -1.41%, compared to POSC's ROE of +9.25%. Regarding short-term risk, QLIS is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs MDXHF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, MDXHF has a market cap of 19.8M. Regarding current trading prices, QLIS is priced at $0.27, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, QLIS's ROE is -1.41%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, QLIS and MDXHF have similar daily volatility (0.00).
QLIS vs GTHP Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, GTHP has a market cap of 19.7M. Regarding current trading prices, QLIS is priced at $0.27, while GTHP trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas GTHP's P/E ratio is -5.00. In terms of profitability, QLIS's ROE is -1.41%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, QLIS is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs DIZTF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, QLIS is priced at $0.27, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, QLIS's ROE is -1.41%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, QLIS is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs PYNKF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, PYNKF has a market cap of 17.6M. Regarding current trading prices, QLIS is priced at $0.27, while PYNKF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas PYNKF's P/E ratio is -0.90. In terms of profitability, QLIS's ROE is -1.41%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, QLIS is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs ASAPF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, ASAPF has a market cap of 17.2M. Regarding current trading prices, QLIS is priced at $0.27, while ASAPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas ASAPF's P/E ratio is -22.00. In terms of profitability, QLIS's ROE is -1.41%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, QLIS and ASAPF have similar daily volatility (0.00).
QLIS vs VPTDF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, VPTDF has a market cap of 16.1M. Regarding current trading prices, QLIS is priced at $0.27, while VPTDF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas VPTDF's P/E ratio is -4.82. In terms of profitability, QLIS's ROE is -1.41%, compared to VPTDF's ROE of +2.34%. Regarding short-term risk, QLIS is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs RMSL Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, RMSL has a market cap of 15M. Regarding current trading prices, QLIS is priced at $0.27, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas RMSL's P/E ratio is 0.98. In terms of profitability, QLIS's ROE is -1.41%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, QLIS is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs TMDIF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, QLIS is priced at $0.27, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, QLIS's ROE is -1.41%, compared to TMDIF's ROE of -1.38%. Regarding short-term risk, QLIS is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs IMEXF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, IMEXF has a market cap of 11.8M. Regarding current trading prices, QLIS is priced at $0.27, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas IMEXF's P/E ratio is N/A. In terms of profitability, QLIS's ROE is -1.41%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, QLIS and IMEXF have similar daily volatility (0.00).
QLIS vs ATBPF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, QLIS is priced at $0.27, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, QLIS's ROE is -1.41%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, QLIS is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs LXXGF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, QLIS is priced at $0.27, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, QLIS's ROE is -1.41%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, QLIS and LXXGF have similar daily volatility (0.00).
QLIS vs ALRTF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, ALRTF has a market cap of 11.1M. Regarding current trading prices, QLIS is priced at $0.27, while ALRTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas ALRTF's P/E ratio is -0.58. In terms of profitability, QLIS's ROE is -1.41%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, QLIS is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs NGMDF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, NGMDF has a market cap of 9.1M. Regarding current trading prices, QLIS is priced at $0.27, while NGMDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas NGMDF's P/E ratio is -4.00. In terms of profitability, QLIS's ROE is -1.41%, compared to NGMDF's ROE of +1.10%. Regarding short-term risk, QLIS and NGMDF have similar daily volatility (0.00).
QLIS vs RHNMF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, QLIS is priced at $0.27, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, QLIS's ROE is -1.41%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, QLIS is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs FZMD Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, FZMD has a market cap of 5.2M. Regarding current trading prices, QLIS is priced at $0.27, while FZMD trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas FZMD's P/E ratio is 1.40. In terms of profitability, QLIS's ROE is -1.41%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, QLIS and FZMD have similar daily volatility (0.00).
QLIS vs IRME Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, IRME has a market cap of 5M. Regarding current trading prices, QLIS is priced at $0.27, while IRME trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas IRME's P/E ratio is -2.33. In terms of profitability, QLIS's ROE is -1.41%, compared to IRME's ROE of +11.77%. Regarding short-term risk, QLIS is less volatile compared to IRME. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs VYCO Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, VYCO has a market cap of 4.4M. Regarding current trading prices, QLIS is priced at $0.27, while VYCO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas VYCO's P/E ratio is -13.21. In terms of profitability, QLIS's ROE is -1.41%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, QLIS and VYCO have similar daily volatility (0.00).
QLIS vs TBRIF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, TBRIF has a market cap of 4.1M. Regarding current trading prices, QLIS is priced at $0.27, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas TBRIF's P/E ratio is -0.90. In terms of profitability, QLIS's ROE is -1.41%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, QLIS and TBRIF have similar daily volatility (0.00).
QLIS vs LBLTF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, LBLTF has a market cap of 4.1M. Regarding current trading prices, QLIS is priced at $0.27, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, QLIS's ROE is -1.41%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, QLIS and LBLTF have similar daily volatility (0.00).
QLIS vs NUMD Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, NUMD has a market cap of 3.9M. Regarding current trading prices, QLIS is priced at $0.27, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas NUMD's P/E ratio is 4.71. In terms of profitability, QLIS's ROE is -1.41%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, QLIS is less volatile compared to NUMD. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs ADMT Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, ADMT has a market cap of 3.8M. Regarding current trading prices, QLIS is priced at $0.27, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas ADMT's P/E ratio is -5.59. In terms of profitability, QLIS's ROE is -1.41%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, QLIS is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs BIEL Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, BIEL has a market cap of 3.6M. Regarding current trading prices, QLIS is priced at $0.27, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas BIEL's P/E ratio is N/A. In terms of profitability, QLIS's ROE is -1.41%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, QLIS is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs VANIW Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, QLIS is priced at $0.27, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas VANIW's P/E ratio is N/A. In terms of profitability, QLIS's ROE is -1.41%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, QLIS is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs PMEDF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, PMEDF has a market cap of 3.1M. Regarding current trading prices, QLIS is priced at $0.27, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas PMEDF's P/E ratio is -1.60. In terms of profitability, QLIS's ROE is -1.41%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, QLIS and PMEDF have similar daily volatility (0.00).
QLIS vs ESMC Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, ESMC has a market cap of 2.4M. Regarding current trading prices, QLIS is priced at $0.27, while ESMC trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas ESMC's P/E ratio is 6.47. In terms of profitability, QLIS's ROE is -1.41%, compared to ESMC's ROE of +0.00%. Regarding short-term risk, QLIS is less volatile compared to ESMC. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs USAQ Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, USAQ has a market cap of 2.4M. Regarding current trading prices, QLIS is priced at $0.27, while USAQ trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas USAQ's P/E ratio is -5.25. In terms of profitability, QLIS's ROE is -1.41%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, QLIS is less volatile compared to USAQ. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs CRRVF Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, CRRVF has a market cap of 1.5M. Regarding current trading prices, QLIS is priced at $0.27, while CRRVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas CRRVF's P/E ratio is N/A. In terms of profitability, QLIS's ROE is -1.41%, compared to CRRVF's ROE of +0.00%. Regarding short-term risk, QLIS and CRRVF have similar daily volatility (0.00).
QLIS vs ODYY Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, ODYY has a market cap of 1.5M. Regarding current trading prices, QLIS is priced at $0.27, while ODYY trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas ODYY's P/E ratio is -0.11. In terms of profitability, QLIS's ROE is -1.41%, compared to ODYY's ROE of +5.81%. Regarding short-term risk, QLIS is less volatile compared to ODYY. This indicates potentially lower risk in terms of short-term price fluctuations for QLIS.
QLIS vs KLYG Comparison
QLIS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QLIS stands at 5.5M. In comparison, KLYG has a market cap of 1.4M. Regarding current trading prices, QLIS is priced at $0.27, while KLYG trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QLIS currently has a P/E ratio of 2.22, whereas KLYG's P/E ratio is -11.50. In terms of profitability, QLIS's ROE is -1.41%, compared to KLYG's ROE of -1.14%. Regarding short-term risk, QLIS and KLYG have similar daily volatility (0.00).